Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results
-
Ventyx Biosciences Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Progress
-
StepStone Group Reports First Quarter Fiscal Year 2026 Results
-
CarGurus Announces Second Quarter 2025 Results & Shares Plans to Wind Down CarOffer Transactions Business
-
Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to September 9, 2025
-
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
-
Quantumsphere Acquisition Corporation Announces Closing of $82,800,000 Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option
-
Inuvo Posts 25% Growth in the Second Quarter 2025
-
Nuvini Launches NuviniAI Lab to Accelerate AI Adoption Across Portfolio Companies and Drive Scalable Growth
-
Resolute Holdings Reports Second Quarter 2025 Results
-
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Whole Foods Market Team Members Vote to Fund $552,350 for Food Access Programs in Colombia, Ghana, Rwanda and the United States
-
HireQuest Reports Financial Results for Second Quarter 2025
-
Dolphin to Host Second Quarter 2025 Earnings Call on August 13 at 4:30 PM ET
-
Alector Reports Second Quarter 2025 Financial Results and Provides Business Update
-
MicroVision Announces Second Quarter 2025 Results
-
Kingsway Reports Second Quarter 2025 Financial Results
-
Nutanix Announces Date and Conference Call Information for Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results
-
The RealReal Announces Second Quarter 2025 Results
-
10x Genomics to Acquire Scale Biosciences
-
Lorne Park Capital Partners Reminds Shareholders to Vote in Connection with Its Upcoming Annual and Special Meeting and Provides Additional Disclosure
-
Texas Roadhouse, Inc. Announces Second Quarter 2025 Results
-
MARPAI TO HOST WEBCAST ON AUGUST 14, 2025 TO DISCUSS SECOND QUARTER 2025 FINANCIAL RESULTS
-
ePlus Announces Initiation of Quarterly Cash Dividend
-
BioLife Solutions Reports Second Quarter 2025 Financial Results
-
Health Catalyst Reports Second Quarter 2025 Results
-
Progyny, Inc. Announces Second Quarter 2025 Results
-
Senvest Capital Inc. Reports Results for the Second Quarter Ended June 30, 2025
-
Dorchester Minerals, L.P. Announces Second Quarter Results
-
ARIS Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Merger of Aris Water Solutions With Western Midstream Partners
-
Key Tronic Corporation Announces Fourth Quarter Reporting and Annual Meeting Date
-
scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
-
ThreeSixty Journalism Concludes 2025 Storytelling Institute for Local Students
-
EXP’s Expansion marks first milestone by joining SR 400 Peach Partners in financial close of Georgia SR 400 Express Lanes Project
-
LegalZoom Reports Strong Second Quarter 2025 Financial Results, Raises 2025 Revenue Growth Expectations
-
Ascendis Pharma Reports Second Quarter 2025 Financial Results
-
Apyx Medical Corporation Reports Second Quarter 2025 Financial Results
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2025 Financial Results
-
Belpointe OZ’s Aster & Links Wins Two Awards
-
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results
-
AudioEye Reports Record Second Quarter 2025 Results
-
AKAMAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
-
Expedia Group Reports Second Quarter 2025 Results
-
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
-
OpenText Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for August 2025
-
Skye Bioscience Reports Second Quarter 2025 Financial Results and Business Update
-
VTEX Reports Second Quarter 2025 Financial Results
